{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:03:51Z","timestamp":1794474231432,"version":"4.9.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jneuroim.2026.579003","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:53:21Z","timestamp":1781308401000},"page":"579003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pre-infusion quantitative EEG features associated with delayed neurocognitive impairment following CAR T-cell therapy"],"prefix":"10.1016","volume":"419","author":[{"given":"Laura","family":"Lopez-Vi\u00f1as","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Fern\u00e1ndez","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Cabezudo-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina D\u00edaz","family":"Aizpun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"G\u00f3mez-Villaboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9 Postigo","family":"Pozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro J.","family":"Serrano-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis Ayala","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2026.579003_bb0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/neuonc\/noab174","article-title":"EEG findings in CAR T-cell-associated neurotoxicity: clinical and radiological correlations","volume":"24","author":"Beuchat","year":"2022","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrclinonc.2017.128","article-title":"Chimeric antigen receptor T-cell therapies for lymphoma","volume":"15","author":"Brudno","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0015","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000212200","article-title":"EEG as a predictive tool for seizures and survival outcomes related to CAR T-cell therapy (P3-9.002)","volume":"104","author":"Chiriboga","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.579003_bb0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbmt.2019.08.003","article-title":"Late events after treatment with CD19-targeted chimeric antigen receptor modified T cells","volume":"26","author":"Cordeiro","year":"2020","journal-title":"J. Am. Soc. Blood Marrow Transplant."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0025","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000191","article-title":"In the eye of the storm: immune-mediated toxicities associated with CAR-T cell therapy","volume":"3","author":"Garcia Borrega","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.jneuroim.2026.579003_bb0030","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1212\/WNL.0000000000005910","article-title":"EEG findings in CAR T-cell therapy-related encephalopathy","volume":"91","author":"Herlopian","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.579003_bb0040","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.clinph.2024.04.014","article-title":"EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndrome","volume":"163","author":"Hernani","year":"2024","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24010-1","article-title":"EEG-based grading of immune effector cell-associated neurotoxicity syndrome","volume":"12","author":"Jones","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0050","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-12-893396","article-title":"Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells","volume":"133","author":"Karschnia","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2026.579003_bb0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-80566-0","article-title":"EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapy","volume":"14","author":"Mao","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0070","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa2024850","article-title":"Idecabtagene vicleucel in relapsed and refractory multiple myeloma","volume":"384","author":"Munshi","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-025-02616-z","article-title":"Objective quantification of pre-CAR-T EEG abnormalities for ICANS prognosis: insights from GTE scoring","author":"Nakagaki","year":"2025","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0085","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0090","doi-asserted-by":"crossref","DOI":"10.1007\/s11940-018-0500-y","article-title":"Ictal interictal continuum patterns","volume":"20","author":"Osman","year":"2018","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0095","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/acn3.51348","article-title":"Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy","volume":"8","author":"Pensato","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0100","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-025-13102-3","article-title":"EEG as a predictive biomarker of neurotoxicity in anti-CD19 CAR T-cell therapy","volume":"272","author":"Pondrelli","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jamaneurol.2016.4990","article-title":"Association of periodic and rhythmic electroencephalographic patterns with seizures in critically ill patients","volume":"74","author":"Rodriguez Ruiz","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0110","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/brain\/awz053","article-title":"Neurological toxicities associated with chimeric antigen receptor T-cell therapy","volume":"142","author":"Rubin","year":"2019","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/19418744221128852","article-title":"Continuous EEG monitoring detects nonconvulsive seizure and ictal-Interictal continuum abnormalities in moderate to severe ICANS following systemic CAR-T therapy","volume":"13","author":"Satyanarayan","year":"2023","journal-title":"The Neurohospitalist"},{"key":"10.1016\/j.jneuroim.2026.579003_bb0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0125","article-title":"Transport study of interleukin-1 inhibitors using a human in vitro model of the blood-brain barrier","volume":"16","author":"Sj\u00f6str\u00f6m","year":"2021","journal-title":"Brain Behav. Immun. - Health"},{"key":"10.1016\/j.jneuroim.2026.579003_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2020-000054","article-title":"Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicity","volume":"2","author":"Sokolov","year":"2020","journal-title":"BMJ Neurol. Open"},{"key":"10.1016\/j.jneuroim.2026.579003_bb0135","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1182\/bloodadvances.2020002328","article-title":"Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma","volume":"4","author":"Strati","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.jneuroim.2026.579003_bb0140","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1914347","article-title":"KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma","volume":"382","author":"Wang","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:59:14Z","timestamp":1791316754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826001529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"alternative-id":["S0165572826001529"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579003","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-infusion quantitative EEG features associated with delayed neurocognitive impairment following CAR T-cell therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"579003"}}